SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Finckh A.)
 

Sökning: WFRF:(Finckh A.) > EULAR points to con...

  • Gossec, L (författare)

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2019-06-22
  • BMJ,2020

Nummerbeteckningar

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:142784882
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142784882URI
  • https://doi.org/10.1136/annrheumdis-2019-215694DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Tremendous opportunities for health research have been unlocked by the recent expansion of big data and artificial intelligence. However, this is an emergent area where recommendations for optimal use and implementation are needed. The objective of these European League Against Rheumatism (EULAR) points to consider is to guide the collection, analysis and use of big data in rheumatic and musculoskeletal disorders (RMDs).MethodsA multidisciplinary task force of 14 international experts was assembled with expertise from a range of disciplines including computer science and artificial intelligence. Based on a literature review of the current status of big data in RMDs and in other fields of medicine, points to consider were formulated. Levels of evidence and strengths of recommendations were allocated and mean levels of agreement of the task force members were calculated.ResultsThree overarching principles and 10 points to consider were formulated. The overarching principles address ethical and general principles for dealing with big data in RMDs. The points to consider cover aspects of data sources and data collection, privacy by design, data platforms, data sharing and data analyses, in particular through artificial intelligence and machine learning. Furthermore, the points to consider state that big data is a moving field in need of adequate reporting of methods and benchmarking, careful data interpretation and implementation in clinical practice.ConclusionThese EULAR points to consider discuss essential issues and provide a framework for the use of big data in RMDs.

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Kedra, J (författare)
  • Servy, H (författare)
  • Pandit, A (författare)
  • Stones, S (författare)
  • Berenbaum, F (författare)
  • Finckh, A (författare)
  • Baraliakos, X (författare)
  • Stamm, TA (författare)
  • Gomez-Cabrero, DKarolinska Institutet (författare)
  • Pristipino, C (författare)
  • Choquet, R (författare)
  • Burmester, GR (författare)
  • Radstake, TRDJ (författare)
  • Karolinska Institutet (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Annals of the rheumatic diseases: BMJ79:1, s. 69-761468-20600003-4967

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy